Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

Northwest Control Systems, LLC, is nearly set to open up shop from its new location in Chehalis at 582 S. Market Blvd. The company, which currently operates in Rochester, purchased the building in May ...

Ben Lamm, CEO of Colossal Biosciences, wanted to ensure his brand was approachable to all, fun, educational and full of ...

Niagen Bioscience CEO Robert Fried discusses the science of NAD, the problems with the supplement industry, and how his company is leading the way in anti-aging research.

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

We recently published 10 Stocks Exploded Over 100%; One Shockingly Soared 11,000%. Regencell Bioscience Holdings Limited ...

A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human ...

Jasper Therapeutics started the year with 64 full-time employees and a robust valuation of more than $320 million. Just seven ...

Harvard Bioscience has yet another leadership shakeup as the Holliston-based biotech firm’s CEO is set to retire and two new ...

Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 '25 revenue anticipated to be $20.4 million and Company reiterates pr ...